Local Institution - 0121

Chuo-ku, Tokyo 104-8560

0 studies enrolling now · 1 studies all time

What they study most

Psoriatic Arthritis

Studies at this site

• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment — Running, not enrolling